nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—HTR2B—migraine	0.353	0.676	CbGaD
Raloxifene—ESR1—migraine	0.169	0.324	CbGaD
Raloxifene—SIGMAR1—Amitriptyline—migraine	0.0952	0.292	CbGbCtD
Raloxifene—HTR6—Amitriptyline—migraine	0.0713	0.219	CbGbCtD
Raloxifene—CYP2B6—Amitriptyline—migraine	0.0257	0.079	CbGbCtD
Raloxifene—CYP2B6—Valproic Acid—migraine	0.0235	0.072	CbGbCtD
Raloxifene—CYP2B6—Verapamil—migraine	0.0204	0.0627	CbGbCtD
Raloxifene—CYP2C8—Amitriptyline—migraine	0.0195	0.0598	CbGbCtD
Raloxifene—CYP2C8—Valproic Acid—migraine	0.0178	0.0545	CbGbCtD
Raloxifene—CYP2C8—Verapamil—migraine	0.0155	0.0475	CbGbCtD
Raloxifene—CYP3A4—Propranolol—migraine	0.00914	0.028	CbGbCtD
Raloxifene—CYP3A4—Amitriptyline—migraine	0.00791	0.0243	CbGbCtD
Raloxifene—CYP3A4—Valproic Acid—migraine	0.00721	0.0221	CbGbCtD
Raloxifene—CYP3A4—Topiramate—migraine	0.0065	0.02	CbGbCtD
Raloxifene—CYP3A4—Verapamil—migraine	0.00628	0.0193	CbGbCtD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR1B—migraine	0.000433	0.00798	CbGpPWpGaD
Raloxifene—HTR2B—Monoamine GPCRs—HTR7—migraine	0.000419	0.00773	CbGpPWpGaD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR1A—migraine	0.000417	0.00768	CbGpPWpGaD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR2C—migraine	0.000403	0.00742	CbGpPWpGaD
Raloxifene—HTR6—Amine ligand-binding receptors—HTR7—migraine	0.000386	0.00712	CbGpPWpGaD
Raloxifene—ESR2—Nuclear Receptors—ESR1—migraine	0.000385	0.00709	CbGpPWpGaD
Raloxifene—CYP19A1—FSH signaling pathway—BDNF—migraine	0.00038	0.007	CbGpPWpGaD
Raloxifene—ESR1—Nuclear Receptors—PGR—migraine	0.000363	0.0067	CbGpPWpGaD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—ESR1—migraine	0.000362	0.00667	CbGpPWpGaD
Raloxifene—ESR2—neck—migraine	0.000359	0.0575	CbGeAlD
Raloxifene—ESR1—Nuclear signaling by ERBB4—PGR—migraine	0.000356	0.00656	CbGpPWpGaD
Raloxifene—Shock—Amitriptyline—migraine	0.000353	0.00386	CcSEcCtD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR7—migraine	0.000353	0.0065	CbGpPWpGaD
Raloxifene—Cerebrovascular accident—Timolol—migraine	0.000352	0.00385	CcSEcCtD
Raloxifene—Vaginal infection—Topiramate—migraine	0.000352	0.00385	CcSEcCtD
Raloxifene—Thrombocytopenia—Amitriptyline—migraine	0.000351	0.00384	CcSEcCtD
Raloxifene—Flushing—Verapamil—migraine	0.000351	0.00384	CcSEcCtD
Raloxifene—Breast disorder—Valproic Acid—migraine	0.00035	0.00383	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Valproic Acid—migraine	0.000349	0.00382	CcSEcCtD
Raloxifene—Hyperhidrosis—Amitriptyline—migraine	0.000347	0.0038	CcSEcCtD
Raloxifene—ESR1—blood vessel—migraine	0.000344	0.055	CbGeAlD
Raloxifene—Cramps of lower extremities—Topiramate—migraine	0.000342	0.00374	CcSEcCtD
Raloxifene—Bladder pain—Topiramate—migraine	0.000337	0.00368	CcSEcCtD
Raloxifene—Influenza—Valproic Acid—migraine	0.000335	0.00367	CcSEcCtD
Raloxifene—Arthritis—Gabapentin—migraine	0.000331	0.00362	CcSEcCtD
Raloxifene—Cerebrovascular accident—Gabapentin—migraine	0.000328	0.00359	CcSEcCtD
Raloxifene—Insomnia—Amitriptyline—migraine	0.000324	0.00355	CcSEcCtD
Raloxifene—Bronchitis—Valproic Acid—migraine	0.000322	0.00353	CcSEcCtD
Raloxifene—HTR6—Monoamine GPCRs—HTR2A—migraine	0.000322	0.00593	CbGpPWpGaD
Raloxifene—Vertigo—Propranolol—migraine	0.000322	0.00352	CcSEcCtD
Raloxifene—Muscle spasms—Verapamil—migraine	0.000316	0.00346	CcSEcCtD
Raloxifene—Migraine—Gabapentin—migraine	0.000316	0.00346	CcSEcCtD
Raloxifene—Dyspepsia—Amitriptyline—migraine	0.000316	0.00346	CcSEcCtD
Raloxifene—Cough—Propranolol—migraine	0.000312	0.00342	CcSEcCtD
Raloxifene—Breast disorder—Timolol—migraine	0.000312	0.00341	CcSEcCtD
Raloxifene—Diabetes mellitus—Topiramate—migraine	0.000311	0.0034	CcSEcCtD
Raloxifene—Gastroenteritis—Topiramate—migraine	0.000305	0.00334	CcSEcCtD
Raloxifene—Weight increased—Valproic Acid—migraine	0.000305	0.00334	CcSEcCtD
Raloxifene—ESR2—Nuclear Receptor transcription pathway—ESR1—migraine	0.000304	0.0056	CbGpPWpGaD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000303	0.00331	CcSEcCtD
Raloxifene—Pneumonia—Valproic Acid—migraine	0.0003	0.00329	CcSEcCtD
Raloxifene—AOX1—trigeminal ganglion—migraine	0.000299	0.0478	CbGeAlD
Raloxifene—Depression—Valproic Acid—migraine	0.000298	0.00326	CcSEcCtD
Raloxifene—Vertigo—Verapamil—migraine	0.000296	0.00324	CcSEcCtD
Raloxifene—Syncope—Verapamil—migraine	0.000295	0.00323	CcSEcCtD
Raloxifene—HTR2B—Monoamine GPCRs—HTR2A—migraine	0.000294	0.00541	CbGpPWpGaD
Raloxifene—Breast disorder—Gabapentin—migraine	0.00029	0.00318	CcSEcCtD
Raloxifene—Conjunctivitis—Valproic Acid—migraine	0.00029	0.00318	CcSEcCtD
Raloxifene—Urinary tract infection—Valproic Acid—migraine	0.00029	0.00318	CcSEcCtD
Raloxifene—Infection—Propranolol—migraine	0.00029	0.00318	CcSEcCtD
Raloxifene—Loss of consciousness—Verapamil—migraine	0.000289	0.00317	CcSEcCtD
Raloxifene—Hot flush—Topiramate—migraine	0.000289	0.00316	CcSEcCtD
Raloxifene—ESR1—Nuclear Receptor transcription pathway—PGR—migraine	0.000287	0.00529	CbGpPWpGaD
Raloxifene—Menopausal symptoms—Topiramate—migraine	0.000286	0.00314	CcSEcCtD
Raloxifene—Nervous system disorder—Propranolol—migraine	0.000286	0.00313	CcSEcCtD
Raloxifene—Sweating—Valproic Acid—migraine	0.000286	0.00313	CcSEcCtD
Raloxifene—Skin disorder—Propranolol—migraine	0.000284	0.0031	CcSEcCtD
Raloxifene—Body temperature increased—Amitriptyline—migraine	0.000284	0.0031	CcSEcCtD
Raloxifene—Myalgia—Verapamil—migraine	0.00028	0.00307	CcSEcCtD
Raloxifene—Arthralgia—Verapamil—migraine	0.00028	0.00307	CcSEcCtD
Raloxifene—Chest pain—Verapamil—migraine	0.00028	0.00307	CcSEcCtD
Raloxifene—Sinusitis—Valproic Acid—migraine	0.00028	0.00307	CcSEcCtD
Raloxifene—Influenza—Gabapentin—migraine	0.000278	0.00304	CcSEcCtD
Raloxifene—ESR2—brainstem—migraine	0.000275	0.0439	CbGeAlD
Raloxifene—HTR6—Amine ligand-binding receptors—HTR2A—migraine	0.000271	0.00499	CbGpPWpGaD
Raloxifene—Rhinitis—Valproic Acid—migraine	0.000269	0.00294	CcSEcCtD
Raloxifene—Bronchitis—Gabapentin—migraine	0.000267	0.00292	CcSEcCtD
Raloxifene—Infection—Verapamil—migraine	0.000267	0.00292	CcSEcCtD
Raloxifene—Hypoaesthesia—Valproic Acid—migraine	0.000267	0.00292	CcSEcCtD
Raloxifene—Pharyngitis—Valproic Acid—migraine	0.000266	0.00291	CcSEcCtD
Raloxifene—Migraine—Topiramate—migraine	0.000266	0.00291	CcSEcCtD
Raloxifene—Depression—Timolol—migraine	0.000265	0.0029	CcSEcCtD
Raloxifene—Urinary tract disorder—Valproic Acid—migraine	0.000265	0.0029	CcSEcCtD
Raloxifene—Shock—Verapamil—migraine	0.000264	0.00289	CcSEcCtD
Raloxifene—Insomnia—Propranolol—migraine	0.000264	0.00289	CcSEcCtD
Raloxifene—Oedema peripheral—Valproic Acid—migraine	0.000264	0.00289	CcSEcCtD
Raloxifene—Connective tissue disorder—Valproic Acid—migraine	0.000263	0.00288	CcSEcCtD
Raloxifene—Urethral disorder—Valproic Acid—migraine	0.000263	0.00288	CcSEcCtD
Raloxifene—ESR1—Estrogen signaling pathway—FOS—migraine	0.000261	0.00482	CbGpPWpGaD
Raloxifene—Hyperhidrosis—Verapamil—migraine	0.00026	0.00284	CcSEcCtD
Raloxifene—Conjunctivitis—Timolol—migraine	0.000258	0.00283	CcSEcCtD
Raloxifene—Dyspepsia—Propranolol—migraine	0.000257	0.00281	CcSEcCtD
Raloxifene—Sweating—Timolol—migraine	0.000255	0.00279	CcSEcCtD
Raloxifene—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—migraine	0.000254	0.00467	CbGpPWpGaD
Raloxifene—Weight increased—Gabapentin—migraine	0.000253	0.00277	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Propranolol—migraine	0.000252	0.00276	CcSEcCtD
Raloxifene—Pain—Propranolol—migraine	0.00025	0.00273	CcSEcCtD
Raloxifene—Sinusitis—Timolol—migraine	0.000249	0.00273	CcSEcCtD
Raloxifene—Pneumonia—Gabapentin—migraine	0.000249	0.00273	CcSEcCtD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR2A—migraine	0.000247	0.00455	CbGpPWpGaD
Raloxifene—Depression—Gabapentin—migraine	0.000247	0.0027	CcSEcCtD
Raloxifene—ESR1—neck—migraine	0.000246	0.0393	CbGeAlD
Raloxifene—Diarrhoea—Amitriptyline—migraine	0.000245	0.00269	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Verapamil—migraine	0.000245	0.00268	CcSEcCtD
Raloxifene—Breast disorder—Topiramate—migraine	0.000244	0.00267	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Topiramate—migraine	0.000243	0.00266	CcSEcCtD
Raloxifene—Angiopathy—Valproic Acid—migraine	0.000243	0.00266	CcSEcCtD
Raloxifene—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000243	0.00448	CbGpPWpGaD
Raloxifene—Insomnia—Verapamil—migraine	0.000243	0.00266	CcSEcCtD
Raloxifene—Conjunctivitis—Gabapentin—migraine	0.000241	0.00263	CcSEcCtD
Raloxifene—Urinary tract infection—Gabapentin—migraine	0.000241	0.00263	CcSEcCtD
Raloxifene—SIGMAR1—trigeminal ganglion—migraine	0.00024	0.0384	CbGeAlD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—PGR—migraine	0.000239	0.00441	CbGpPWpGaD
Raloxifene—Rhinitis—Timolol—migraine	0.000239	0.00262	CcSEcCtD
Raloxifene—Gastrointestinal pain—Propranolol—migraine	0.000239	0.00261	CcSEcCtD
Raloxifene—Sweating—Gabapentin—migraine	0.000237	0.0026	CcSEcCtD
Raloxifene—Dizziness—Amitriptyline—migraine	0.000237	0.0026	CcSEcCtD
Raloxifene—Dyspepsia—Verapamil—migraine	0.000236	0.00259	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—HTR1A—migraine	0.000236	0.00436	CbGpPWpGaD
Raloxifene—Oedema peripheral—Timolol—migraine	0.000235	0.00257	CcSEcCtD
Raloxifene—Connective tissue disorder—Timolol—migraine	0.000235	0.00257	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TAC1—migraine	0.000233	0.00429	CbGpPWpGaD
Raloxifene—Sinusitis—Gabapentin—migraine	0.000232	0.00254	CcSEcCtD
Raloxifene—Abdominal pain—Propranolol—migraine	0.000231	0.00253	CcSEcCtD
Raloxifene—Body temperature increased—Propranolol—migraine	0.000231	0.00253	CcSEcCtD
Raloxifene—Flatulence—Valproic Acid—migraine	0.00023	0.00252	CcSEcCtD
Raloxifene—Pain—Verapamil—migraine	0.00023	0.00251	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000228	0.00421	CbGpPWpGaD
Raloxifene—Vomiting—Amitriptyline—migraine	0.000228	0.0025	CcSEcCtD
Raloxifene—Rash—Amitriptyline—migraine	0.000226	0.00248	CcSEcCtD
Raloxifene—Dermatitis—Amitriptyline—migraine	0.000226	0.00247	CcSEcCtD
Raloxifene—Headache—Amitriptyline—migraine	0.000225	0.00246	CcSEcCtD
Raloxifene—Bronchitis—Topiramate—migraine	0.000225	0.00246	CcSEcCtD
Raloxifene—Muscle spasms—Valproic Acid—migraine	0.000224	0.00246	CcSEcCtD
Raloxifene—ESR2—cardiovascular system—migraine	0.000224	0.0358	CbGeAlD
Raloxifene—Rhinitis—Gabapentin—migraine	0.000223	0.00244	CcSEcCtD
Raloxifene—Cardiac disorder—Timolol—migraine	0.000222	0.00242	CcSEcCtD
Raloxifene—Hypoaesthesia—Gabapentin—migraine	0.000221	0.00242	CcSEcCtD
Raloxifene—Pharyngitis—Gabapentin—migraine	0.000221	0.00241	CcSEcCtD
Raloxifene—Urinary tract disorder—Gabapentin—migraine	0.00022	0.0024	CcSEcCtD
Raloxifene—Oedema peripheral—Gabapentin—migraine	0.000219	0.0024	CcSEcCtD
Raloxifene—Connective tissue disorder—Gabapentin—migraine	0.000218	0.00239	CcSEcCtD
Raloxifene—Urethral disorder—Gabapentin—migraine	0.000218	0.00238	CcSEcCtD
Raloxifene—Angiopathy—Timolol—migraine	0.000217	0.00237	CcSEcCtD
Raloxifene—HTR6—head—migraine	0.000216	0.0345	CbGeAlD
Raloxifene—Nausea—Amitriptyline—migraine	0.000213	0.00233	CcSEcCtD
Raloxifene—Weight increased—Topiramate—migraine	0.000213	0.00233	CcSEcCtD
Raloxifene—Vertigo—Valproic Acid—migraine	0.00021	0.0023	CcSEcCtD
Raloxifene—Pneumonia—Topiramate—migraine	0.00021	0.00229	CcSEcCtD
Raloxifene—Depression—Topiramate—migraine	0.000208	0.00227	CcSEcCtD
Raloxifene—Cardiac disorder—Gabapentin—migraine	0.000206	0.00226	CcSEcCtD
Raloxifene—HTR6—nervous system—migraine	0.000205	0.0328	CbGeAlD
Raloxifene—Cough—Valproic Acid—migraine	0.000204	0.00223	CcSEcCtD
Raloxifene—Conjunctivitis—Topiramate—migraine	0.000202	0.00222	CcSEcCtD
Raloxifene—Urinary tract infection—Topiramate—migraine	0.000202	0.00222	CcSEcCtD
Raloxifene—Diarrhoea—Propranolol—migraine	0.0002	0.00219	CcSEcCtD
Raloxifene—Arthralgia—Valproic Acid—migraine	0.000199	0.00217	CcSEcCtD
Raloxifene—Chest pain—Valproic Acid—migraine	0.000199	0.00217	CcSEcCtD
Raloxifene—Myalgia—Valproic Acid—migraine	0.000199	0.00217	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000197	0.00216	CcSEcCtD
Raloxifene—HTR6—central nervous system—migraine	0.000197	0.0315	CbGeAlD
Raloxifene—Sinusitis—Topiramate—migraine	0.000195	0.00214	CcSEcCtD
Raloxifene—Dizziness—Propranolol—migraine	0.000193	0.00211	CcSEcCtD
Raloxifene—Flatulence—Gabapentin—migraine	0.000191	0.00209	CcSEcCtD
Raloxifene—Infection—Valproic Acid—migraine	0.000189	0.00207	CcSEcCtD
Raloxifene—ESR1—brainstem—migraine	0.000188	0.0301	CbGeAlD
Raloxifene—Rhinitis—Topiramate—migraine	0.000187	0.00205	CcSEcCtD
Raloxifene—Nervous system disorder—Valproic Acid—migraine	0.000187	0.00204	CcSEcCtD
Raloxifene—Vertigo—Timolol—migraine	0.000187	0.00204	CcSEcCtD
Raloxifene—Thrombocytopenia—Valproic Acid—migraine	0.000187	0.00204	CcSEcCtD
Raloxifene—Syncope—Timolol—migraine	0.000186	0.00204	CcSEcCtD
Raloxifene—Hypoaesthesia—Topiramate—migraine	0.000186	0.00204	CcSEcCtD
Raloxifene—Muscle spasms—Gabapentin—migraine	0.000186	0.00204	CcSEcCtD
Raloxifene—Vomiting—Propranolol—migraine	0.000186	0.00203	CcSEcCtD
Raloxifene—Pharyngitis—Topiramate—migraine	0.000186	0.00203	CcSEcCtD
Raloxifene—HTR6—G alpha (s) signalling events—NPS—migraine	0.000186	0.00342	CbGpPWpGaD
Raloxifene—Skin disorder—Valproic Acid—migraine	0.000185	0.00203	CcSEcCtD
Raloxifene—Urinary tract disorder—Topiramate—migraine	0.000185	0.00202	CcSEcCtD
Raloxifene—Oedema peripheral—Topiramate—migraine	0.000184	0.00202	CcSEcCtD
Raloxifene—Hyperhidrosis—Valproic Acid—migraine	0.000184	0.00202	CcSEcCtD
Raloxifene—Rash—Propranolol—migraine	0.000184	0.00202	CcSEcCtD
Raloxifene—Dermatitis—Propranolol—migraine	0.000184	0.00201	CcSEcCtD
Raloxifene—Diarrhoea—Verapamil—migraine	0.000184	0.00201	CcSEcCtD
Raloxifene—Connective tissue disorder—Topiramate—migraine	0.000184	0.00201	CcSEcCtD
Raloxifene—Urethral disorder—Topiramate—migraine	0.000183	0.00201	CcSEcCtD
Raloxifene—Loss of consciousness—Timolol—migraine	0.000183	0.002	CcSEcCtD
Raloxifene—Cough—Timolol—migraine	0.000181	0.00198	CcSEcCtD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00018	0.00331	CbGpPWpGaD
Raloxifene—Dizziness—Verapamil—migraine	0.000178	0.00194	CcSEcCtD
Raloxifene—Chest pain—Timolol—migraine	0.000177	0.00194	CcSEcCtD
Raloxifene—Myalgia—Timolol—migraine	0.000177	0.00194	CcSEcCtD
Raloxifene—Arthralgia—Timolol—migraine	0.000177	0.00194	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000176	0.00192	CcSEcCtD
Raloxifene—Vertigo—Gabapentin—migraine	0.000174	0.0019	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Valproic Acid—migraine	0.000174	0.0019	CcSEcCtD
Raloxifene—Flushing—Topiramate—migraine	0.000174	0.0019	CcSEcCtD
Raloxifene—Cardiac disorder—Topiramate—migraine	0.000174	0.0019	CcSEcCtD
Raloxifene—Syncope—Gabapentin—migraine	0.000174	0.0019	CcSEcCtD
Raloxifene—Nausea—Propranolol—migraine	0.000173	0.0019	CcSEcCtD
Raloxifene—HTR2B—cardiovascular system—migraine	0.000173	0.0277	CbGeAlD
Raloxifene—Insomnia—Valproic Acid—migraine	0.000172	0.00189	CcSEcCtD
Raloxifene—Vomiting—Verapamil—migraine	0.000171	0.00187	CcSEcCtD
Raloxifene—HTR6—G alpha (s) signalling events—CALCA—migraine	0.00017	0.00314	CbGpPWpGaD
Raloxifene—Loss of consciousness—Gabapentin—migraine	0.00017	0.00186	CcSEcCtD
Raloxifene—Angiopathy—Topiramate—migraine	0.00017	0.00186	CcSEcCtD
Raloxifene—Rash—Verapamil—migraine	0.000169	0.00185	CcSEcCtD
Raloxifene—Dermatitis—Verapamil—migraine	0.000169	0.00185	CcSEcCtD
Raloxifene—Cough—Gabapentin—migraine	0.000169	0.00185	CcSEcCtD
Raloxifene—Infection—Timolol—migraine	0.000168	0.00184	CcSEcCtD
Raloxifene—Headache—Verapamil—migraine	0.000168	0.00184	CcSEcCtD
Raloxifene—Dyspepsia—Valproic Acid—migraine	0.000168	0.00184	CcSEcCtD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000167	0.00308	CbGpPWpGaD
Raloxifene—Shock—Timolol—migraine	0.000167	0.00183	CcSEcCtD
Raloxifene—Nervous system disorder—Timolol—migraine	0.000166	0.00182	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—BDNF—migraine	0.000166	0.00306	CbGpPWpGaD
Raloxifene—Arthralgia—Gabapentin—migraine	0.000165	0.0018	CcSEcCtD
Raloxifene—Myalgia—Gabapentin—migraine	0.000165	0.0018	CcSEcCtD
Raloxifene—Chest pain—Gabapentin—migraine	0.000165	0.0018	CcSEcCtD
Raloxifene—Skin disorder—Timolol—migraine	0.000165	0.0018	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Valproic Acid—migraine	0.000164	0.0018	CcSEcCtD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000164	0.00302	CbGpPWpGaD
Raloxifene—Hyperhidrosis—Timolol—migraine	0.000164	0.00179	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000164	0.00179	CcSEcCtD
Raloxifene—Pain—Valproic Acid—migraine	0.000163	0.00178	CcSEcCtD
Raloxifene—HTR6—GPCR ligand binding—RAMP1—migraine	0.000161	0.00297	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CALCRL—migraine	0.000161	0.00297	CbGpPWpGaD
Raloxifene—ESR1—FOXM1 transcription factor network—FOS—migraine	0.000161	0.00297	CbGpPWpGaD
Raloxifene—Flatulence—Topiramate—migraine	0.00016	0.00176	CcSEcCtD
Raloxifene—Nausea—Verapamil—migraine	0.00016	0.00175	CcSEcCtD
Raloxifene—HTR6—G alpha (s) signalling events—HTR7—migraine	0.000159	0.00294	CbGpPWpGaD
Raloxifene—Infection—Gabapentin—migraine	0.000157	0.00172	CcSEcCtD
Raloxifene—HTR6—brain—migraine	0.000157	0.025	CbGeAlD
Raloxifene—Muscle spasms—Topiramate—migraine	0.000157	0.00171	CcSEcCtD
Raloxifene—Gastrointestinal pain—Valproic Acid—migraine	0.000156	0.0017	CcSEcCtD
Raloxifene—ESR1—FOXA1 transcription factor network—FOS—migraine	0.000155	0.00287	CbGpPWpGaD
Raloxifene—Shock—Gabapentin—migraine	0.000155	0.0017	CcSEcCtD
Raloxifene—Nervous system disorder—Gabapentin—migraine	0.000155	0.00169	CcSEcCtD
Raloxifene—Thrombocytopenia—Gabapentin—migraine	0.000155	0.00169	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Timolol—migraine	0.000154	0.00169	CcSEcCtD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000154	0.00284	CbGpPWpGaD
Raloxifene—ESR1—cardiovascular system—migraine	0.000153	0.0245	CbGeAlD
Raloxifene—Skin disorder—Gabapentin—migraine	0.000153	0.00168	CcSEcCtD
Raloxifene—Insomnia—Timolol—migraine	0.000153	0.00168	CcSEcCtD
Raloxifene—Hyperhidrosis—Gabapentin—migraine	0.000153	0.00167	CcSEcCtD
Raloxifene—ESR2—head—migraine	0.000152	0.0243	CbGeAlD
Raloxifene—Abdominal pain—Valproic Acid—migraine	0.000151	0.00165	CcSEcCtD
Raloxifene—Body temperature increased—Valproic Acid—migraine	0.000151	0.00165	CcSEcCtD
Raloxifene—Dyspepsia—Timolol—migraine	0.000149	0.00163	CcSEcCtD
Raloxifene—HTR2B—GPCR ligand binding—CALCRL—migraine	0.000147	0.00272	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—RAMP1—migraine	0.000147	0.00272	CbGpPWpGaD
Raloxifene—Gastrointestinal disorder—Timolol—migraine	0.000146	0.0016	CcSEcCtD
Raloxifene—Vertigo—Topiramate—migraine	0.000146	0.0016	CcSEcCtD
Raloxifene—Syncope—Topiramate—migraine	0.000146	0.0016	CcSEcCtD
Raloxifene—Pain—Timolol—migraine	0.000145	0.00159	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Gabapentin—migraine	0.000144	0.00157	CcSEcCtD
Raloxifene—ESR2—nervous system—migraine	0.000144	0.023	CbGeAlD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000143	0.00264	CbGpPWpGaD
Raloxifene—Loss of consciousness—Topiramate—migraine	0.000143	0.00157	CcSEcCtD
Raloxifene—Insomnia—Gabapentin—migraine	0.000143	0.00156	CcSEcCtD
Raloxifene—Cough—Topiramate—migraine	0.000142	0.00155	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000141	0.0026	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000141	0.00259	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—HTR2A—migraine	0.00014	0.00258	CbGpPWpGaD
Raloxifene—Dyspepsia—Gabapentin—migraine	0.000139	0.00152	CcSEcCtD
Raloxifene—Gastrointestinal pain—Timolol—migraine	0.000139	0.00152	CcSEcCtD
Raloxifene—Chest pain—Topiramate—migraine	0.000139	0.00152	CcSEcCtD
Raloxifene—Myalgia—Topiramate—migraine	0.000139	0.00152	CcSEcCtD
Raloxifene—Arthralgia—Topiramate—migraine	0.000139	0.00152	CcSEcCtD
Raloxifene—ESR2—central nervous system—migraine	0.000139	0.0221	CbGeAlD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000138	0.00151	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Gabapentin—migraine	0.000136	0.00149	CcSEcCtD
Raloxifene—ESR2—cerebellum—migraine	0.000135	0.0216	CbGeAlD
Raloxifene—Pain—Gabapentin—migraine	0.000135	0.00148	CcSEcCtD
Raloxifene—Abdominal pain—Timolol—migraine	0.000134	0.00147	CcSEcCtD
Raloxifene—Body temperature increased—Timolol—migraine	0.000134	0.00147	CcSEcCtD
Raloxifene—Infection—Topiramate—migraine	0.000132	0.00144	CcSEcCtD
Raloxifene—EBP—Metabolism—CACNA1A—migraine	0.000131	0.00242	CbGpPWpGaD
Raloxifene—Shock—Topiramate—migraine	0.000131	0.00143	CcSEcCtD
Raloxifene—Diarrhoea—Valproic Acid—migraine	0.00013	0.00143	CcSEcCtD
Raloxifene—AOX1—cerebellum—migraine	0.00013	0.0208	CbGeAlD
Raloxifene—Nervous system disorder—Topiramate—migraine	0.00013	0.00143	CcSEcCtD
Raloxifene—Thrombocytopenia—Topiramate—migraine	0.00013	0.00142	CcSEcCtD
Raloxifene—Gastrointestinal pain—Gabapentin—migraine	0.000129	0.00141	CcSEcCtD
Raloxifene—Skin disorder—Topiramate—migraine	0.000129	0.00141	CcSEcCtD
Raloxifene—Hyperhidrosis—Topiramate—migraine	0.000128	0.00141	CcSEcCtD
Raloxifene—Dizziness—Valproic Acid—migraine	0.000126	0.00138	CcSEcCtD
Raloxifene—Abdominal pain—Gabapentin—migraine	0.000125	0.00137	CcSEcCtD
Raloxifene—Body temperature increased—Gabapentin—migraine	0.000125	0.00137	CcSEcCtD
Raloxifene—ESR1—ATF-2 transcription factor network—FOS—migraine	0.000123	0.00227	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—NPS—migraine	0.000122	0.00225	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—TAC1—migraine	0.000122	0.00225	CbGpPWpGaD
Raloxifene—Vomiting—Valproic Acid—migraine	0.000121	0.00133	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Topiramate—migraine	0.000121	0.00132	CcSEcCtD
Raloxifene—Insomnia—Topiramate—migraine	0.00012	0.00132	CcSEcCtD
Raloxifene—Rash—Valproic Acid—migraine	0.00012	0.00131	CcSEcCtD
Raloxifene—Dermatitis—Valproic Acid—migraine	0.00012	0.00131	CcSEcCtD
Raloxifene—ESR1—Signaling by ERBB4—PGR—migraine	0.00012	0.00221	CbGpPWpGaD
Raloxifene—CYP19A1—head—migraine	0.00012	0.0191	CbGeAlD
Raloxifene—HTR2B—G alpha (q) signalling events—HTR2C—migraine	0.00012	0.0022	CbGpPWpGaD
Raloxifene—Headache—Valproic Acid—migraine	0.000119	0.00131	CcSEcCtD
Raloxifene—HTR2B—head—migraine	0.000117	0.0188	CbGeAlD
Raloxifene—HTR6—GPCR ligand binding—HTR1D—migraine	0.000117	0.00216	CbGpPWpGaD
Raloxifene—Dyspepsia—Topiramate—migraine	0.000117	0.00128	CcSEcCtD
Raloxifene—HTR2B—G alpha (q) signalling events—EDNRA—migraine	0.000116	0.00214	CbGpPWpGaD
Raloxifene—Diarrhoea—Timolol—migraine	0.000116	0.00127	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Topiramate—migraine	0.000115	0.00126	CcSEcCtD
Raloxifene—Pain—Topiramate—migraine	0.000114	0.00124	CcSEcCtD
Raloxifene—CYP2B6—cardiovascular system—migraine	0.000113	0.0181	CbGeAlD
Raloxifene—CYP19A1—nervous system—migraine	0.000113	0.0181	CbGeAlD
Raloxifene—Nausea—Valproic Acid—migraine	0.000113	0.00124	CcSEcCtD
Raloxifene—Dizziness—Timolol—migraine	0.000112	0.00123	CcSEcCtD
Raloxifene—HTR2B—nervous system—migraine	0.000111	0.0178	CbGeAlD
Raloxifene—ESR2—brain—migraine	0.00011	0.0176	CbGeAlD
Raloxifene—ESR1—Regulation of Telomerase—FOS—migraine	0.00011	0.00202	CbGpPWpGaD
Raloxifene—CYP19A1—central nervous system—migraine	0.000109	0.0175	CbGeAlD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000109	0.00201	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000109	0.00201	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR2B—migraine	0.000109	0.00201	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000109	0.00201	CbGpPWpGaD
Raloxifene—Gastrointestinal pain—Topiramate—migraine	0.000109	0.00119	CcSEcCtD
Raloxifene—Diarrhoea—Gabapentin—migraine	0.000108	0.00118	CcSEcCtD
Raloxifene—Vomiting—Timolol—migraine	0.000108	0.00118	CcSEcCtD
Raloxifene—ESR2—Generic Transcription Pathway—NOTCH4—migraine	0.000108	0.00198	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—FOS—migraine	0.000107	0.00198	CbGpPWpGaD
Raloxifene—HTR2B—central nervous system—migraine	0.000107	0.0171	CbGeAlD
Raloxifene—HTR2B—GPCR ligand binding—HTR1D—migraine	0.000107	0.00197	CbGpPWpGaD
Raloxifene—Rash—Timolol—migraine	0.000107	0.00117	CcSEcCtD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000107	0.00197	CbGpPWpGaD
Raloxifene—Dermatitis—Timolol—migraine	0.000107	0.00117	CcSEcCtD
Raloxifene—Headache—Timolol—migraine	0.000106	0.00116	CcSEcCtD
Raloxifene—AOX1—brain—migraine	0.000106	0.0169	CbGeAlD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000106	0.00195	CbGpPWpGaD
Raloxifene—Abdominal pain—Topiramate—migraine	0.000105	0.00115	CcSEcCtD
Raloxifene—Body temperature increased—Topiramate—migraine	0.000105	0.00115	CcSEcCtD
Raloxifene—SIGMAR1—cerebellum—migraine	0.000105	0.0168	CbGeAlD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000105	0.00193	CbGpPWpGaD
Raloxifene—Dizziness—Gabapentin—migraine	0.000104	0.00114	CcSEcCtD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000104	0.00192	CbGpPWpGaD
Raloxifene—ESR1—head—migraine	0.000104	0.0166	CbGeAlD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000101	0.00187	CbGpPWpGaD
Raloxifene—Nausea—Timolol—migraine	0.000101	0.0011	CcSEcCtD
Raloxifene—Vomiting—Gabapentin—migraine	0.0001	0.0011	CcSEcCtD
Raloxifene—Rash—Gabapentin—migraine	9.96e-05	0.00109	CcSEcCtD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—migraine	9.96e-05	0.00184	CbGpPWpGaD
Raloxifene—Dermatitis—Gabapentin—migraine	9.95e-05	0.00109	CcSEcCtD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.94e-05	0.00183	CbGpPWpGaD
Raloxifene—Headache—Gabapentin—migraine	9.89e-05	0.00108	CcSEcCtD
Raloxifene—ESR1—nervous system—migraine	9.85e-05	0.0158	CbGeAlD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	9.85e-05	0.00182	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—PGR—migraine	9.84e-05	0.00181	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	9.57e-05	0.00176	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	9.54e-05	0.00176	CbGpPWpGaD
Raloxifene—ESR1—central nervous system—migraine	9.49e-05	0.0152	CbGeAlD
Raloxifene—Nausea—Gabapentin—migraine	9.38e-05	0.00103	CcSEcCtD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	9.33e-05	0.00172	CbGpPWpGaD
Raloxifene—ESR1—cerebellum—migraine	9.27e-05	0.0148	CbGeAlD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	9.24e-05	0.0017	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—NOTCH3—migraine	9.14e-05	0.00169	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CALCRL—migraine	9.12e-05	0.00168	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—RAMP1—migraine	9.12e-05	0.00168	CbGpPWpGaD
Raloxifene—Diarrhoea—Topiramate—migraine	9.09e-05	0.000995	CcSEcCtD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.99e-05	0.00166	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	8.98e-05	0.00166	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TGFBR2—migraine	8.91e-05	0.00164	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR7—migraine	8.87e-05	0.00163	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.84e-05	0.00163	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.84e-05	0.00163	CbGpPWpGaD
Raloxifene—Dizziness—Topiramate—migraine	8.79e-05	0.000962	CcSEcCtD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	8.67e-05	0.0016	CbGpPWpGaD
Raloxifene—CYP19A1—brain—migraine	8.67e-05	0.0139	CbGeAlD
Raloxifene—SIGMAR1—brain—migraine	8.52e-05	0.0136	CbGeAlD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.52e-05	0.00157	CbGpPWpGaD
Raloxifene—HTR2B—brain—migraine	8.5e-05	0.0136	CbGeAlD
Raloxifene—Vomiting—Topiramate—migraine	8.45e-05	0.000925	CcSEcCtD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	8.44e-05	0.00156	CbGpPWpGaD
Raloxifene—Rash—Topiramate—migraine	8.38e-05	0.000917	CcSEcCtD
Raloxifene—Dermatitis—Topiramate—migraine	8.37e-05	0.000916	CcSEcCtD
Raloxifene—HTR2B—GPCR downstream signaling—CALCRL—migraine	8.33e-05	0.00153	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—RAMP1—migraine	8.33e-05	0.00153	CbGpPWpGaD
Raloxifene—Headache—Topiramate—migraine	8.32e-05	0.000911	CcSEcCtD
Raloxifene—HTR6—Signaling by GPCR—RAMP1—migraine	8.28e-05	0.00153	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CALCRL—migraine	8.28e-05	0.00153	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	8.2e-05	0.00151	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	8.09e-05	0.00149	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.07e-05	0.00149	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.07e-05	0.00149	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—TNF—migraine	8.07e-05	0.00149	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.92e-05	0.00146	CbGpPWpGaD
Raloxifene—Nausea—Topiramate—migraine	7.89e-05	0.000864	CcSEcCtD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.7e-05	0.00142	CbGpPWpGaD
Raloxifene—CYP2B6—head—migraine	7.68e-05	0.0123	CbGeAlD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	7.6e-05	0.0014	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—RAMP1—migraine	7.56e-05	0.00139	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CALCRL—migraine	7.56e-05	0.00139	CbGpPWpGaD
Raloxifene—ESR1—brain—migraine	7.53e-05	0.012	CbGeAlD
Raloxifene—HTR2B—G alpha (q) signalling events—HTR2A—migraine	7.33e-05	0.00135	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CACNA1A—migraine	7.28e-05	0.00134	CbGpPWpGaD
Raloxifene—CYP2B6—nervous system—migraine	7.28e-05	0.0116	CbGeAlD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—ESR1—migraine	7.19e-05	0.00132	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	7.11e-05	0.00131	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR1B—migraine	7.1e-05	0.00131	CbGpPWpGaD
Raloxifene—CYP2B6—central nervous system—migraine	7.01e-05	0.0112	CbGeAlD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.93e-05	0.00128	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR1A—migraine	6.84e-05	0.00126	CbGpPWpGaD
Raloxifene—AOX1—Disease—LRP1—migraine	6.82e-05	0.00126	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—NPS—migraine	6.73e-05	0.00124	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—TAC1—migraine	6.73e-05	0.00124	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR1D—migraine	6.63e-05	0.00122	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR2C—migraine	6.6e-05	0.00122	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	6.56e-05	0.00121	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR1B—migraine	6.48e-05	0.0012	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—EDNRA—migraine	6.43e-05	0.00118	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR1A—migraine	6.24e-05	0.00115	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.21e-05	0.00114	CbGpPWpGaD
Raloxifene—CYP2C8—brain—migraine	6.2e-05	0.00992	CbGeAlD
Raloxifene—HTR6—GPCR ligand binding—CALCA—migraine	6.18e-05	0.00114	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2B—migraine	6.16e-05	0.00114	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—NPS—migraine	6.15e-05	0.00113	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—TAC1—migraine	6.15e-05	0.00113	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR1D—migraine	6.05e-05	0.00112	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR2C—migraine	6.03e-05	0.00111	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—migraine	6.02e-05	0.00111	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR1D—migraine	6.02e-05	0.00111	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—EDNRA—migraine	5.86e-05	0.00108	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR7—migraine	5.78e-05	0.00107	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.67e-05	0.00104	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CALCA—migraine	5.65e-05	0.00104	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2B—migraine	5.59e-05	0.00103	CbGpPWpGaD
Raloxifene—CYP2B6—brain—migraine	5.56e-05	0.0089	CbGeAlD
Raloxifene—CYP3A4—nervous system—migraine	5.5e-05	0.00879	CbGeAlD
Raloxifene—HTR2B—Signaling by GPCR—HTR1D—migraine	5.49e-05	0.00101	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NOTCH4—migraine	5.42e-05	0.001	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.32e-05	0.000981	CbGpPWpGaD
Raloxifene—CYP3A4—central nervous system—migraine	5.29e-05	0.00846	CbGeAlD
Raloxifene—HTR2B—GPCR ligand binding—HTR7—migraine	5.28e-05	0.000973	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—ESR1—migraine	5.25e-05	0.000968	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NOTCH4—migraine	5.18e-05	0.000954	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.12e-05	0.000944	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—PGR—migraine	4.96e-05	0.000914	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CALCRL—migraine	4.89e-05	0.000902	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RAMP1—migraine	4.89e-05	0.000902	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.86e-05	0.000895	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—PGR—migraine	4.74e-05	0.000873	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NOTCH3—migraine	4.61e-05	0.00085	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CALCRL—migraine	4.47e-05	0.000823	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RAMP1—migraine	4.47e-05	0.000823	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NOTCH3—migraine	4.4e-05	0.000811	CbGpPWpGaD
Raloxifene—AOX1—Disease—CALCA—migraine	4.4e-05	0.000811	CbGpPWpGaD
Raloxifene—EBP—Metabolism—MTHFR—migraine	4.35e-05	0.000801	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HTR2A—migraine	4.05e-05	0.000747	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR1B—migraine	4.01e-05	0.00074	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR1A—migraine	3.86e-05	0.000712	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TAC1—migraine	3.81e-05	0.000702	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—NPS—migraine	3.81e-05	0.000702	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CACNA1A—migraine	3.77e-05	0.000694	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2C—migraine	3.73e-05	0.000688	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RAMP1—migraine	3.72e-05	0.000686	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CALCRL—migraine	3.72e-05	0.000686	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR2A—migraine	3.7e-05	0.000682	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR1B—migraine	3.66e-05	0.000676	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR1B—migraine	3.65e-05	0.000672	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—EDNRA—migraine	3.63e-05	0.000669	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR1D—migraine	3.55e-05	0.000655	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFBR2—migraine	3.54e-05	0.000653	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR1A—migraine	3.53e-05	0.00065	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR1A—migraine	3.51e-05	0.000647	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CALCA—migraine	3.5e-05	0.000644	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TAC1—migraine	3.47e-05	0.00064	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—NPS—migraine	3.47e-05	0.00064	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TAC1—migraine	3.46e-05	0.000637	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—NPS—migraine	3.46e-05	0.000637	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR2C—migraine	3.41e-05	0.000628	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2C—migraine	3.39e-05	0.000625	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR1B—migraine	3.33e-05	0.000613	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—EDNRA—migraine	3.31e-05	0.000611	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2B—migraine	3.3e-05	0.000609	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EDNRA—migraine	3.3e-05	0.000608	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR7—migraine	3.27e-05	0.000603	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR1D—migraine	3.24e-05	0.000598	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR1A—migraine	3.2e-05	0.000591	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CALCA—migraine	3.19e-05	0.000588	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CALCA—migraine	3.17e-05	0.000585	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—NPS—migraine	3.15e-05	0.000582	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TAC1—migraine	3.15e-05	0.000582	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR2C—migraine	3.09e-05	0.00057	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EDNRA—migraine	3.01e-05	0.000555	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR7—migraine	2.98e-05	0.00055	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR7—migraine	2.97e-05	0.000547	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LRP1—migraine	2.91e-05	0.000536	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CALCA—migraine	2.9e-05	0.000534	CbGpPWpGaD
Raloxifene—AOX1—Disease—MTHFR—migraine	2.88e-05	0.00053	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR7—migraine	2.71e-05	0.0005	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR1D—migraine	2.7e-05	0.000498	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LRP1—migraine	2.66e-05	0.00049	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NOTCH4—migraine	2.61e-05	0.000481	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.58e-05	0.000476	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—ESR1—migraine	2.53e-05	0.000466	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2B—migraine	2.51e-05	0.000463	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CACNA1A—migraine	2.42e-05	0.000446	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MTHFR—migraine	2.41e-05	0.000444	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PGR—migraine	2.39e-05	0.00044	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2A—migraine	2.29e-05	0.000422	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOTCH4—migraine	2.23e-05	0.000412	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NOTCH3—migraine	2.22e-05	0.000409	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LRP1—migraine	2.21e-05	0.000408	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR1B—migraine	2.15e-05	0.000397	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR2A—migraine	2.09e-05	0.000385	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2A—migraine	2.08e-05	0.000383	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR1A—migraine	2.07e-05	0.000382	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CACNA1A—migraine	2.05e-05	0.000377	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NPS—migraine	2.04e-05	0.000376	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TAC1—migraine	2.04e-05	0.000376	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PGR—migraine	2.04e-05	0.000376	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOTCH4—migraine	2.04e-05	0.000376	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2C—migraine	2e-05	0.000369	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR1B—migraine	1.97e-05	0.000362	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EDNRA—migraine	1.95e-05	0.000359	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOTCH3—migraine	1.9e-05	0.00035	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR2A—migraine	1.9e-05	0.00035	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR1A—migraine	1.89e-05	0.000349	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CALCA—migraine	1.87e-05	0.000346	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TAC1—migraine	1.86e-05	0.000344	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PGR—migraine	1.86e-05	0.000344	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NPS—migraine	1.86e-05	0.000344	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR2C—migraine	1.83e-05	0.000337	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EDNRA—migraine	1.78e-05	0.000328	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR7—migraine	1.75e-05	0.000323	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOTCH3—migraine	1.73e-05	0.000319	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CALCA—migraine	1.71e-05	0.000315	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH4—migraine	1.7e-05	0.000313	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR1B—migraine	1.64e-05	0.000302	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR7—migraine	1.6e-05	0.000295	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR1A—migraine	1.58e-05	0.000291	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NPS—migraine	1.55e-05	0.000286	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TAC1—migraine	1.55e-05	0.000286	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PGR—migraine	1.55e-05	0.000286	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2C—migraine	1.52e-05	0.000281	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFBR2—migraine	1.51e-05	0.000278	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EDNRA—migraine	1.48e-05	0.000273	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH3—migraine	1.44e-05	0.000266	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CALCA—migraine	1.43e-05	0.000263	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFBR2—migraine	1.38e-05	0.000254	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR7—migraine	1.33e-05	0.000246	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTHFR—migraine	1.25e-05	0.00023	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2A—migraine	1.23e-05	0.000226	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFBR2—migraine	1.15e-05	0.000212	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR2A—migraine	1.12e-05	0.000207	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CACNA1A—migraine	1.1e-05	0.000203	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ESR1—migraine	1.09e-05	0.000201	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ESR1—migraine	9.95e-06	0.000183	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—migraine	9.34e-06	0.000172	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—migraine	8e-06	0.000147	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—migraine	6.77e-06	0.000125	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—migraine	3.64e-06	6.7e-05	CbGpPWpGaD
